← FDA DRUG APPROVALS

FDA ANDA · ANDA090468

ZYFREL

Sponsor: CYPRESS PHARM INC

APPLICATION
ANDA090468
TYPE
ANDA
ORIGINAL APPROVAL
2016-04-14
LATEST ACTION
2017-11-28
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ZYFRELDiscontinued
ACETAMINOPHEN 325MG/15ML, HYDROCODONE BITARTRATE 7.5MG/15ML · SOLUTION · ORAL

Approval history

2017-11-28Labeling · Supplement 3 · standardAP
2016-12-16Labeling · Supplement 2 · standardAP
2016-04-14OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →